Drug & intervention

tisotumab vedotin

RxCUI 2571094

Clinical trials2

Recruiting0

Related conditions12

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

2 shown

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsNCT03485209 · 2018-06-25

ACTIVE_NOT_RECRUITING

Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.NCT03245736 · 2017-08-23

Conditions being studied

Bladder Cancer1 Carcinoma, Non-Small-Cell Lung1 Carcinoma, Squamous Cell of Head and Neck1 Cervix Cancer1 Colorectal Neoplasms1 Endometrium Cancer1 Esophagus Cancer1 Exocrine Pancreatic Cancer1 Lung Cancer, Nonsmall Cell1 Ovary Cancer1 Prostate Cancer1 Squamous Cell Carcinoma of the Head and Neck1

Research locations

AtlantaGeorgia, United States1 BaltimoreMaryland, United States1 BarcelonaSpain1 BarcelonaCatalonia, Spain1 BostonMassachusetts, United States1 Chapel HillNorth Carolina, United States1 CharlottesvilleVirginia, United States1 ChicagoIllinois, United States1 CommackNew York, United States1 DetroitMichigan, United States1 DurhamNorth Carolina, United States1 EdmontonAlberta, Canada1

Leading sponsors

Seagen Inc.1 Seagen, a wholly owned subsidiary of Pfizer1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.